Lakeshore Biopharma Co Ltd's ROI from its fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lakeshore Biopharma Co Ltd's ROI in the fourth quarter of 2024?
Lakeshore Biopharma Co Ltd recorded a cumulative net loss of $-61 million during 12 months ending in the fourth quarter of 2024, resulting in a negative return on investment (ROI) of -56.94%.

Within the Healthcare sector 634 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2024 from 0 to 3945.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Mar 31 2023) IV. Quarter
Y / Y Investment Change TTM	-27.95 %	-33.58 %	-29.99 %	-2.24 %	45.9 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	129	100	100	100	146
Return On Investment (TTM)	-56.94 %	-18.98 %	-17.08 %	-15.52 %	-14.22 %
LSB's Overall Ranking	# 3945	# 0	# 0	# 0	# 0
Seq. Investment Change TTM	-3.79 %	-10.05 %	-9.14 %	-8.37 %	-11.31 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-61	-21	-21	-21	-21

LSB Company Profile >> Back to LSB Roi Comparisons >> See Annual LSB Return On Investment

Return On Investment LSB's Ranking
Within:	No.
Industry	# 273
Sector	# 635
Overall	# 3945

Return On Investment Statistics
High	Average	Low
-60.98 %	-60.98 %	-60.98 %
(Mar 31 2024)

Financial Statements
Lakeshore Biopharma Co Ltd's IV. Quarter Investments	$ 129 Millions	LSB's Balance sheet
Lakeshore Biopharma Co Ltd's IV. Quarter Income	$ -61 Millions	Quarterly LSB's Income Statement
LSB's Income by Division		See LSB's Income by Division

LSB Annual Return On Investment	(Mar 31 2025) 2025	(Mar 31 2024) 2024	(Mar 31 2023) 2023
Total Investments in Millions	129	146	222	0	0
Y / Y Investment Growth	-11.61 %	-34.31 %	-	-	-
Net Income in Millions	-2	-61	-21	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-1.5 %	-41.99 %	-9.56 %	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LSB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LSB's Competitors
Subscribers only: Roi for Lakeshore Biopharma Co Ltd's Suppliers
Subscribers only: Return On Investment for LSB's Customers

Other Ratios
LSB's Roa	LSB's Inventory Turnover Ratio	LSB's Growth Rates	LSB's Dividend Statistics
	LSB's Profitability Ratios	LSB's Asset Turnover Ratio	LSB's Dividend Growth
LSB's Roe	LSB's Valuation Ratios	LSB's Financial Strength Ratios	LSB's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2024, within Healthcare Sector

ROI

Date modified: 2026-09-08T15:11:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.